tirzepatide bone loss Does Cause Osteoporosis? Evidence and Health tirzepatide and bone loss Positive

The suppressed hepatic glucose production and expression of gluconeogenic genes induced by intracerebral ventricular insulin infusion is impaired in liver-specific STAT3 deficiency mice and in IL-6 deficient mice (Inoue et al., 2006)

Salt form variations: The FDA has noted that some compounded products use salt forms of semaglutide (such as semaglutide sodium or semaglutide acetate) rather than semaglutide base

other GLP-1 injections: site considerations If you have experience injecting semaglutide, tirzepatide, or other GLP-1 receptor agonists, most of that knowledge transfers directly to retatrutide

That was an investigational trial protocol, not an approved label, and no SAHPRA, FDA or EMA authorisation exists for retatrutide as of 2026